EPID-13. IDENTIFICATION OF PROGNOSTIC MARKERS IN A COHORT OF CONSECUTIVE NON-SELECTED GLIOBLASTOMA PATIENTS RECEIVING STANDARD THERAPY

Glioblastoma is treated by standard with maximal surgical resection followed by radiation therapy with concomitant and adjuvant temozolomide. Still, median overall survival (OS) for glioblastoma is around 15 months, although the prognosis varies greatly. To improve the treatment, stratification of g...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Regner Michaelsen, Signe, Urup, Thomas, Grunnet, Kirsten, Jarle Christensen, Ib, Lassen, Ulrik, Skovgaard Poulsen, Hans
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Epidemiology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847771/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.313
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares